Keytruda is generically known as PEMBROLIZUMAB. Immunotherapy X thanks to its action in the body that the drug is used to treat cancer. The drug is prepared and enters the body by intravenous injection.

When cancer begins in one part of the body and spreads to another, it is called metastasis. Brain metastases are when primary lung cancer has produced one or more secondary tumors in the brain.

Kết quả điều trị tích cực khi sử dụng thuốc miễn dịch Pembrolizumab (Keytruda) là tín hiệu đáng mừng cho bệnh nhân ung thư, đặc biệt là người bệnh ung thư giai đoạn muộn, di căn

Pembrolizumab (Keytruda) is one of a number of immunosuppressive cancer drugs. The following article briefly presents the results of a newly published study of Pembrolizumab (Keytruda) for advanced gastric and esophageal cancer.